Insulin secretion in the early phase of type 1 diabetes mellitus (T1DM) and new hopes for maintaining it through therapy

Magdalena Żalińska; Małgorzata Szmigiero-Kawko; Agnieszka Brandt; Piotr Trzonkowski; Małgorzata Myśliwiec

eISSN: 2083-8441
ISSN: 2081-237X

Pediatric Endocrinology Diabetes and Metabolism

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

Journal integrated with

3/2016
vol. 22

Send email

Copy url:

abstract:

Review paper

Insulin secretion in the early phase of type 1 diabetes mellitus (T1DM) and new hopes for maintaining it through therapy

Magdalena Żalińska

,

Małgorzata Szmigiero-Kawko

,

Agnieszka Brandt

,

Piotr Trzonkowski

,

Małgorzata Myśliwiec

Online publish date: 2017/06/18

View full text Get citation

Type 1 diabetes mellitus (T1DM) is an autoimmune disease with a progressive loss of pancreatic beta cell functional mass and subsequent impairment of insulin secretion. At present, the most important factors that help sustain insulin secretion at the early stage of the disease and have the potential to reduce the risk or even prevent long-term diabetic complications include early diagnosis, early initiation of the insulin therapy, an appropriate education of patients and immunotherapeutic interventions. In this paper, the issue of insulin secretion at the early stage of T1DM and some of the most recent research on novel therapies supporting traditional treatments are discussed.

keywords:

Insulin secretion in the early phase of type 1 diabetes mellitus (T1DM) and new hopes for maintaining it through therapy

Magdalena Żalińska , Małgorzata Szmigiero-Kawko , Agnieszka Brandt , Piotr Trzonkowski , Małgorzata Myśliwiec

type 1 diabetes, insulin secretion, clinical remission, beta cells, immune intervention

Magdalena Żalińska

,

Małgorzata Szmigiero-Kawko

,

Agnieszka Brandt

,

Piotr Trzonkowski

,

Małgorzata Myśliwiec